Pharmabiz11m
EMA accepts for review regulatory application of GSK’s Shingrix new prefilled syringe presentation for prevention of shingles
EMA accepts for review regulatory application of GSK’s Shingrix new prefilled syringe presentation for prevention of shingles: London, UK Wednesday, January 29, 2025, 13:00 Hrs ...
Pharmabiz56m
AIPAC in collaboration with MMC, SPDS, IPA, IDMA, Tamil Nadu Chapter hosts international symposium on dissolution science and drug development
Our Bureau, Mumbai Wednesday, January 29, 2025, 12:15 Hrs [IST] ...
Pharmabiz1h
Neurocrine Biosciences and Takeda amend strategic collaboration to develop and commercialize osavampator
Neurocrine Biosciences, Inc., is a leading neuroscience-focused, biopharmaceutical company, announced it has amended its agreement with Takeda to develop and commercialize osavampator (NBI-1065845/TAK ...
Pharmabiz1h
Indian Pharmaceutical Association- Karnataka State Branch elects Dr M Khalid Khan as president
Indian Pharmaceutical Association- Karnataka State Branch elects Dr M Khalid Khan as president: Our Bureau, Bengaluru Wednesday, January 29, 2025, 11:15 Hrs [IST] Indian Pharmaceu ...
Pharmabiz4h
EMA accepts for review GSK’s MAA for depemokimab for use in asthma with type 2 inflammation and CRSwNP
EMA accepts for review GSK’s MAA for depemokimab for use in asthma with type 2 inflammation and CRSwNP: London, UK Wednesday, January 29, 2025, 09:00 Hrs [IST] GSK plc announced ...
Pharmabiz5h
Future of glaucoma research holds immense promise with AI, gene and stem cell therapy: Dr Davinder Tyagi
Nandita Vijayasimha, Bengaluru Wednesday, January 29, 2025, 08:00 Hrs [IST] ...
Pharmabiz5h
Indian pharma faces decline in R&D productivity, patent expiries, turns to AI to mitigate challenges
Nandita Vijayasimha, Bengaluru Wednesday, January 29, 2025, 08:00 Hrs [IST] ...
Pharmabiz5h
SEC asks SII to submit more data for approval of recombinant mAB for dengue treatment in adults
SEC asks SII to submit more data for approval of recombinant mAB for dengue treatment in adults: Our Bureau, New Delhi Wednesday, January 29, 2025, 08:00 Hrs [IST] The Subject Exp ...
Pharmabiz5h
NOW QUALITY IS KING
The Parliamentary Standing Committee on the Union Ministry of Chemicals and Fertilisers has recently asked the Pharmaceuticals & Medical Devices Bureau of India (PMBI), which is the implementing ...
Pharmabiz5h
Panel asks Centre to sensitize states on best practices for licensing of Class A and B devices
Gireesh Babu, New Delhi Wednesday, January 29, 2025, 08:00 Hrs [IST] ...
Pharmabiz5h
DGFT grants relief in average export obligation under EPCG Scheme
DGFT grants relief in average export obligation under EPCG Scheme: Shardul Nautiyal, Mumbai Wednesday, January 29, 2025, 08:00 Hrs [IST] The Directorate General of Foreign Trade ( ...
Pharmabiz19h
Lupin receives US FDA approval for generic Atrovent nasal spray, 0.06%
Lupin receives US FDA approval for generic Atrovent nasal spray, 0.06%: Our Bureau,Mumbai Tuesday, January 28, 2025, 17:30 Hrs [IST] Global pharma major Lupin Limited (Lupin) anno ...